Código QR

Therapeutic efficacy of ruxolitinib combined with low-dose hormone in aGVHD after allogeneic hematopoietic stem cell transplantation

[Objective] To evaluate the efficacy and safety of ruxolitinib combined with low-dose hormone for patients with acute graft-versus-host disease (aGVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT). [Methods] Thirty patients with aGVHD after allo-HSCT admitted to the Departmen...

Descrición completa

Gardado en:
Principais autores: HU Yue, ZHANG Xupai, LAI Sihan, ZHANG Shan, MA Lei, WANG Xiao, DENG Yan, HAN Ying, HE Ying, HE Guangcui, YI Hai
Formato: Artigo
Idioma:Chinês
Publicado: Institute of Blood Transfusion of Chinese Academy of Medical Sciences 2026-04-01
Series:Zhongguo shuxue zazhi
Assuntos:
ruxolitinib
glucocorticoid
allogeneic hematopoietic stem cell transplantation (allo-hsct)
acute graft versus host disease (agvhd)
Acceso en liña:https://www.cjbt.cn/thesisDetails#10.13303/j.cjbt.issn.1004-549x.2026.04.013&lang=en
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares